Evaluation of the Safety and Effectiveness of the Investigational Product in Improvement of the Appearance of Wrinkles and General Aspect of the Skin

Inclusion Criteria: * Participants aged between 30 and 55 years old; * Participants with all skin types (normal, dry, combination and oily); * Participants with mild to moderate signs of aging, according to Lanier's classification; * Participants with melanic and/or vascular dark circles; * Participants with bags around their eyes; * Users of products from the same category; * Intact skin in the product analysis region (face); * Participants who agree NOT to use any other topical products on the test area during the study period; * Agreement to comply with the trial procedures and to attend the clinic on the specified days and times; * Understand, consent and sign the informed consent. Exclusion Criteria: * Participants diagnosed with COVID-19 in the last 4 weeks or showing symptoms such as fever, dry cough, tiredness, body aches or other discomfort; * Pregnancy/lactation or intention to become pregnant during the study period; * Use of the following topical or systemic medications: immunosuppressants, antihistamines, non-steroidal anti-inflammatory drugs, and corticoids up to 30 days before selection or considering immunosuppressants, the interval should be 3 months before selection; * Atopic or allergic history of health products; * Pathologies and/or active skin lesions (local and/or disseminated) in the assessment area; * Skin marks in the experimental area that interfere with the evaluation of possible skin reactions (vascular malformations, scars, increased hairiness, large amounts of nevus, sunburn); * Immunosuppression by drugs or active diseases; * Decompensated endocrinopathies; * Participants with known congenital or acquired immunodeficiency; * Relevant medical history or current evidence of alcohol or other drug abuse; * Known history or suspected intolerance to products in the same category * Intense sun exposure up to 15 days before the assessment; * Aesthetic or dermatological treatment in the evaluation area up to 04 weeks before selection; * Professionals directly involved in carrying out this study; * Other conditions considered by the evaluating physician as reasonable for disqualification from participating in the study. If yes, it should be described in observation in the clinical record